Los Angeles, CANCT05928052Now EnrollingIRB Ready

Respiratory Distress Syndrome Clinical Trial in Los Angeles, CA

Access cutting-edge respiratory distress syndrome treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by University of California, Los Angeles

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access respiratory distress syndrome specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related respiratory distress syndrome treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this respiratory distress syndrome clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Respiratory Distress Syndrome Study in Los Angeles

This is an early phase, proof-of-concept clinical trial assessing the safety and feasibility of non-invasive spinal cord stimulation to prevent respiratory muscle atrophy in mechanically ventilated ARDS patients. The investigators will recruit 10 elective surgery patients (surgery cohort) and 10 ARDS patients (ARDS cohort) for this study. A non-invasive, alpha-prototype Restore Technology stimulator using hydrogel surface electrodes will be used to stimulate the spinal cord at the cervical or thoracic level.

Sponsor: University of California, Los Angeles

Who Can Participate

Inclusion Criteria

Male or female 18-85 years;
Intubated with confirmed diagnosis of ARDS (by Berlin Criteria: acute onset within one week of known insult, bilateral airspace opacities not fully explained by pleural effusions, atelectasis, and/or nodules, respiratory failure not explained by heart failure or fluid overload, PaO2/FiO2 ratio \< 300); or identified as a patient admitted to the intensive care unit (ICU) after non-cardiac surgery;
Able to provide informed consent or available next of kin able to provide informed consent;
Have intact chest/lung, upper and lower extremity anatomy;
The neuromuscular connections between the spinal cord, diaphragm, and intercostal muscles are intact;
Enrollment of subject within 48 hours of intubation;
Able to induce evoked response of diaphragm muscle by spinal cord TES.

Exclusion Criteria

Phrenic nerve or diaphragm pacer;
History of seizure disorder or on anti-epileptic medication for the treatment of seizures;
Compromised skin in back (neck, upper and lower back);
Implanted devices: cardiac pacemakers, implanted defibrillators, implanted neurostimulators, phrenic nerve pacers;
BMI greater than or equal to 35;
Pharmacological paralysis/neuromuscular blockade\*.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT05928052) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Respiratory Distress Syndrome Treatment Options in Los Angeles, CA

If you're searching for respiratory distress syndrome treatment options in Los Angeles, CA, this clinical trial (NCT05928052) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced respiratory distress syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all respiratory distress syndrome clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Los Angeles, CA

See all rheumatoid arthritis clinical trials recruiting in Los Angeles — not just this study.

Browse Rheumatoid Arthritis Trials in Los Angeles →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA